Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

637
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
637
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

952
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
952
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

517
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
517
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

894
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
894
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

746
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
746
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

450
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
450

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-risk Sexual Behavior for HIV Acquisition is Associated with Gut Microbial Community in Men Who Have Sex with Men.

Open forum infectious diseases·2025
Same author

Evaluation of Mobile Intermittent Fasting Applications in Chinese App Stores: Quality Evaluations and Content Analysis.

JMIR mHealth and uHealth·2025
Same author

Tenofovir to Prevent HIV Infection in Western China: Pragmatic Randomized Controlled Trial.

JMIR public health and surveillance·2025
Same author

Significant associations between high-risk sexual behaviors and enterotypes of gut microbiome in HIV-negative men who have sex with men.

mSphere·2025
Same author

Minority Stress and Intimate Violence Perpetration Among Men Who Have Sex With Men in China: Hazardous Alcohol Use as a Meditator.

Sexually transmitted diseases·2025
Same author

Influencing factors of HCV testing willingness among men who have sex with men in China: A structural equation modeling analysis.

PloS one·2025

Related Experiment Video

Updated: Jan 15, 2026

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
07:38

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

8.7K

Decoding IBD progression: a dynamic biomarker atlas for personalized disease stratification.

Yi Tao1,2, Lin-F Wang3, Pan Li4

  • 1Phase I Clinical Trial Ward, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.

Journal of Translational Medicine
|October 11, 2025
PubMed
Summary

This study reveals how gut microbiota and host gene expression can accurately stage inflammatory bowel disease (IBD) non-invasively. Integrating multi-omics data improves precision for personalized IBD treatment strategies.

Keywords:
Gut microbiotaInflammatory bowel diseaseMachine learningNetMossStackingTranscriptomics

More Related Videos

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

8.0K
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

48.5K

Related Experiment Videos

Last Updated: Jan 15, 2026

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
07:38

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

8.7K
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

8.0K
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

48.5K

Area of Science:

  • Gastroenterology
  • Microbiome Research
  • Genomics

Background:

  • Accurate inflammatory bowel disease (IBD) staging is crucial for effective treatment and patient outcomes.
  • Intestinal microbiota and host transcriptional profiles are key determinants in IBD progression.
  • Non-invasive biomarkers are needed for predicting IBD severity and guiding personalized therapies.

Purpose of the Study:

  • To develop a multi-omics framework for non-invasive IBD staging.
  • To identify microbial and host transcriptional biomarkers for IBD stratification.
  • To integrate multi-omics data for enhanced prediction of IBD severity.

Main Methods:

  • Integrated multi-omics analysis of fecal and serum samples from 97 participants (IBD patients and healthy controls).
  • 16S rRNA sequencing for microbial profiling and RNA-seq for host transcriptomics.
  • Network-based (NetMoss) and machine learning (REF-SVM, Stacking Classifier) approaches for biomarker discovery and predictive modeling.

Main Results:

  • Identified clinical dysregulations and reduced microbial alpha-diversity in IBD patients.
  • Discovered stage-specific microbial taxa (e.g., Bifidobacterium, Bacteroides) and host gene expression markers (e.g., YIPF4, HBB, TUBB1).
  • Multi-omics integration achieved high accuracy (AUCs ~0.80) in IBD staging, revealing microbial-host interactions.

Conclusions:

  • Established a multi-omics framework for non-invasive IBD staging.
  • Demonstrated the clinical utility of combining microbial and transcriptomic data for precise IBD stratification.
  • Findings support the potential of multi-omics biomarkers to transform IBD management and therapeutic interventions.